NEW DELHI, April 11, 2017: CORE Diagnostics is partnering with Silicon Valley-based CellMax Life to immediately introduce CellMax Life’s genetic cancer risk test and ctDNA-based liquid biopsy throughout India. The two diagnostic advancements hold immense promise to reduce India’s cancer mortality by offering personalized, precision cancer risk assessment and screening.
*Our customer care team will reach out to you for scheduling the sample collection at the defined intervals
*Our customer care team will reach out to you for scheduling the sample collection at the defined intervals
*The Diagnostic Monitoring Tests will be done once the Free Trial Period is over
*Our customer care team will reach out to you for scheduling the sample collection at the defined intervals
*The Diagnostic Monitoring Tests will be done once the Free Trial Period is over
*Our customer care team will reach out to you for scheduling the sample collection at the defined intervals
